by EpicentRx | Jan 18, 2013 | Conferences
January 2013, La Jolla, California Abstract: Antivascular activity of RRx-001 in SCCVII and U87 tumors Abstract: RRx-001: A novel hypoxia activated nitric oxide generating vascular disrupting agent (VDA) Abstract: Preliminary results from an ongoing phase I trial of...
by EpicentRx | Dec 18, 2012 | Conferences
December 2012, Atlanta Georgia Abstract: Treatment with a novel dinitroazetidine, ABDNAZ, improves nitrite reductase activity of sickle red blood cells
by EpicentRx | Mar 18, 2012 | Conferences
March 2012, Chicago Illinois Abstract: RRx-001 modulates intratumor blood flow in SCCVII and U87 tumors
by EpicentRx | Dec 18, 2011 | Conferences
December 2011, San Diego, California Abstract: NO or no NO, increased reduction of nitrite to nitric oxide by modified red blood cells
by EpicentRx | Apr 18, 2011 | Conferences
April 2011, Atlanta, Georgia Abstract: Disposition of 14C-RRx-001 in rats after a single intravenous administration and in blood from rats, dogs, monkeys, and humans
